NCT05893121 Evaluation of a Cardiac Coherence Session to Reducing Patients' Anxiety During a MRI Examination
| NCT ID | NCT05893121 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Toulouse |
| Condition | Anxiety |
| Study Type | OBSERVATIONAL |
| Enrollment | 60 participants |
| Start Date | 2023-12-08 |
| Primary Completion | 2026-03-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 60 participants in total. It began in 2023-12-08 with a primary completion date of 2026-03-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The present project aims at conducting a proof of concept study to explore the pertinence of a single session of cardiac coherence, carried out in patients prior to an MRI examination and presenting anxiety in relation to this examination, to reduce their level of anxiety and thus improve the course of the examination.
Eligibility Criteria
Inclusion Criteria: * Person affiliated to or benefiting from a social security scheme; * Free, informed and written consent signed by the participant and the investigator (at the latest on the day of inclusion and before any examination required by the research); * Patient to undergo an MRI examination of the upper half of the body * Patient over 18 years old * Patient with a high level of anxiety (score ≥ 4) in relation to MRI Non-inclusion Criteria: * Patient under legal protection or under another protection regime (guardianship, curatorship). * Sedated or unconscious patient * Patient performing an emergency MRI examination * Patient with a level of French language that does not allow sufficient understanding for the completion of questionnaires Exclusion criteria: \- STAI Y-A score \< 46 (insignificant or low anxiety)
Contact & Investigator
Jean-Pierre DESIRAT
PRINCIPAL INVESTIGATOR
University Hospital, Toulouse
Frequently Asked Questions
Who can join the NCT05893121 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Anxiety. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05893121 currently recruiting?
Yes, NCT05893121 is actively recruiting participants. Contact the research team at desirat.jp@chu-toulouse.fr for enrollment information.
Where is the NCT05893121 trial being conducted?
This trial is being conducted at Toulouse, France.
Who is sponsoring the NCT05893121 clinical trial?
NCT05893121 is sponsored by University Hospital, Toulouse. The principal investigator is Jean-Pierre DESIRAT at University Hospital, Toulouse. The trial plans to enroll 60 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.